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Interferon Therapy and Natural Killer Activity m 
Intracranial Tumor-Bearing Mice 
SHIN-ICHI OTSUKA, KINYA SUDAへJUNKOHYAMASHITA 
Ju;r TAKEUC町、 HAJIMERANDA 
Department of Neurosurgery, Kyoto University l¥ledical School 
*Department of Neurosurgery, Shiga Medical School 
Effect of interferon (IFN) on survival time and natural killer (NK) activity of spleen cells 
was studied in intracranial tumor-bearing mice. IFJ¥ therapy was started 3 days after the 
intracranial transplantation of 203-glioma cells in C57BL mice. 1×105じ ofIF.N were admin-
istered intraperitoneally 4 times a week for 5 weeks. There was no remarkable effect of IF:¥ 
therapy on survival time in intracranial tumor bearing mice. l¥K activity of spleen cells in 
these mice was serially examined by th巴methodof 51Cr release assay. N K activity of spleen cells 
in intracranial tumor-bearing mice treated with IFN increased after the administration of IFI¥ 
and high level of NK activity was maintained during IFN therapy. But NK activity rapidly 
decreased to the same level of intracranial tumor-bearing mice without IFN therapy one week 
after the termination of IFN therapy. In this study there seemed to be no correlation between 
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日目， 1週間目， 11日目， 2週間目， 3週間目， 4週
間目， 5週間目，および IF：＼投与終了後1週間目の
計8回測定した＿ KK活性の測定は， Fig.1 ~c示した

























Count of radioacti、・ityin supernatant 
Fig. 1. The method of 51Cr release assay for NK 
activity of spleen cells in mice. Tモ汀ector凹 ls
(spleen cells) and target cells (VAC 1 cells) 
labelled with日Crwere mixed at various ra-
tios and incubated for 6 hours at 3TC in a 
humidi五edatmosphere containing 5% C02. 
After incubation, radioactivity of supernatant 
was counted in a well-typed gamma counter. 
マウスより無菌的lとspleenを摘出，細切し， tris-:¥H4-
Cl液lとて赤血球を溶血除去し， spleencel 浮遊液を作








gamma counter (ALO KA AUTO ¥¥"ELL GA'¥DIA 
日’STE：＼！人RC-500）で放射能活性を測定し，次式に
より算出した劣 specific51Cr releaseを NK活性とし
fこ．
ER-SR 
% specific 31Cr release＝可哀二百R×100
ER: experimental release；被検サンフ。ルより放出，丙R
Spontaneous release; target cellのみ培養したもの，
:¥IR: maximum release; NP-40 detergentを含む培養
液で培養したもの， assayは各群2匹ずつの7 ウスの
spleenを合わせ， duplicateで行なった.Fig. 2は，種
々の targetcel と effectorcelの比（T:Eratio）にお
ける正常 C57BL＜ ウスの spleencel の， YAC-1細
胞に対する cytotoxicityを示したものであるが， T:E
ratio k応じた dosedependentの NK活性が認められ，
今回の実験では T E ratioは1・50で行なった．なお
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Effector: Target cel rat10 
Fig. 2. :¥ k 以 ti、ityof spleen cells in normal mice. 
NK acti口tyof spleen cells from normal mice 
ari ・ shown in relation to various e仔ectorto 
target cel ratios. 
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assay lζ使用した培養液は， 10~ぢ fetal calf serum添加




















spleen celの NK活性の変動は， Fig.4 Iと示したよ
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11 
weeks after transplantation 
E百ectof IFN therapy on survival time in intracranial tumor-bearing mice. 
（一一） intracranial tumor-bearing mice without IFN therapy 
（ 一） intracranial tumor-bearing mice with IFN therapy 
Each group consisted of 10 mice. 
IFN therapy was started 3 days after intracranial transplantation of tumor 
1×105 C of IFN were administered intraperitoneally 4 times a week for 5 weeks 
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Change of 1'i K activity of spleen cells during 1 Fl¥ therapy in intra cranial tumor-
bearing mice. 
（ 一一） normal mice 
（ー一一） intracranial tumor-bearing mice without IFN therapy 
（ー一一） intracranial tumor-hearing mice ¥Yith IFN therapy 
The target to effector cel ratio was 1・50.
About 20~ 。 of % spec1抗c51Cr release was ooserved in normal mice. In intracra-
nial tumor-bearing mice without IF/¥ therapy, ="i K acti、ityincreased 4 days after 
transplantation and high level of NK activity continued untill 7 days after tran-
splantation. But 11 dav与aftertransplantation, NK activity decreased to the same 
level of normal mice. in intracranial tumor-bearing mice treated with IFN, ;'¥ K おおおrd~~f~g仕込a［；~rr：~；~r'f；~t~~i~r:p~nd 品、店以i~とおl~ii~~~
辻、edto the same level of intracranial tumor-oeanng mice w】thoutIF!¥ therapy one 







と考えられるようになった. in 、j,・oにおいて NK細
胞の抗腫療効果を認めたという報告もあるJO＞•この
l'iK細胞の IF／＼による活性増強作用は， 7 ウスやヒ
トで認められている 12,13, 18）.我々は，今回の実験で































を欠〈ヌー ドマウスで XK活性が高くへ しかも他の
純系マウスと比較しでも癌自然発生率に差がない乙と
但頭蓋内腫湯マウスにおけるインターフエロン療法と naturalkiller活性 71 
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